A team at the Rambam Health Care Campus and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology in Haifa, studied 127 HD patients, of whom 37 had PHT. The condition was present in 17 patients before starting HD and developed in 20 patients after HD initiation. These two subgroups had similar survival, which was significantly worse when compared with subjects without PHT.
Continue Reading
In multivariable analysis, development of PHT before and after the start of HD was independently associated with a 3.6 and 2.1 times increased risk of death, respectively, compared with patients who did not have PHT.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.